B-lymphoblastoid/JJ
cell/NN
lines/NNS
from/IN
multiple/JJ
sclerosis/NN
patients/NNS
and/CC
a/DT
healthy/JJ
control/NN
producing/VBG
a/DT
putative/JJ
new/JJ
human/JJ
retrovirus/NN
and/CC
Epstein-Barr/JJ
virus/NN
./.

On/IN
several/JJ
occasions/NNS
we/PRP
have/VBP
observed/VBN
retrovirus-like/JJ
particles/NNS
(/(
RVLPs/NNS
)/)
by/IN
transmission/NN
electron/NN
microscopy/NN
(/(
EM/NN
)/)
of/IN
cultured/VBN
T/NN
cells/NNS
from/IN
a/DT
patient/NN
with/IN
MS/NN
./.
=====
Later/RB
we/PRP
established/VBD
spontaneously/RB
formed/VBN
B-lymphoblastoid/JJ
cell/NN
lines/NNS
(/(
LCLs/NNS
)/)
from/IN
a/DT
patient/NN
with/IN
an/DT
MS-like/JJ
disease/NN
and/CC
from/IN
another/DT
patient/NN
with/IN
MS/NN
who/WP
had/VBD
a/DT
reactivated/VBN
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
infection/NN
./.
=====
Both/DT
LCLs/NNS
were/VBD
found/VBN
by/IN
EM/NN
to/TO
produce/VB
RVLP/NN
and/CC
EBV/NN
particles/NNS
./.
=====
Reverse/JJ
transcriptase/NN
(/(
RT/NN
)/)
assays/NNS
were/VBD
positive/JJ
in/IN
purified/VBN
viral/JJ
material/NN
from/IN
both/DT
LCLs/NNS
./.
=====
To/TO
substantiate/VB
these/DT
findings/NNS
we/PRP
initiated/VBD
an/DT
intensified/VBN
culturing/NN
procedure/NN
and/CC
were/VBD
able/JJ
to/TO
establish/VB
LCLs/NNS
from/IN
5/CD
out/RB
of/IN
21/CD
consecutive/JJ
MS/NN
patients/NNS
and/CC
1/CD
out/RB
of/IN
13/CD
consecutive/JJ
healthy/JJ
controls/NNS
./.
=====
All/DT
LCLs/NNS
were/VBD
found/VBN
to/TO
produce/VB
both/CC
RVLP/NN
and/CC
EBV/NN
particles/NNS
by/IN
EM/NN
./.
=====
Whether/IN
the/DT
putative/JJ
new/JJ
retrovirus/NN
(/(
es/NNS
)/)
and/CC
EBV/NN
have/VBP
any/DT
causal/JJ
relationship/NN
to/TO
MS/NN
is/VBZ
still/RB
not/RB
known/VBN
,/,
but/CC
the/DT
findings/NNS
support/VBP
this/DT
possibility/NN
./.